NDC 76282-115 – Lamivudine and Zidovudine

Lamivudine 150 mg/1; Zidovudine 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC76282-115

Product details

Brand name
Lamivudine and Zidovudine
Generic name
Lamivudine and Zidovudine
Labeler
Exelan Pharmaceuticals Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA203259
Marketed since
April 29, 2015
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for LAMIVUDINE and ZIDOVUDINE →

Package NDC codes (2)

Package NDCDescriptionSince
76282-115-05500 TABLET, FILM COATED in 1 BOTTLE (76282-115-05)Apr 29, 2015
76282-115-6060 TABLET, FILM COATED in 1 BOTTLE (76282-115-60)Apr 29, 2015

Other LAMIVUDINE and ZIDOVUDINE products